Home
>
National Drug Code (NDC)
>
Valacyclovir Hydrochloride
Valacyclovir Hydrochloride - 51079-093-03 - (valacyclovir hydrochloride)
Drug Information of Valacyclovir Hydrochloride
| Product NDC: | 51079-093 |
| Proprietary Name: | Valacyclovir Hydrochloride |
| Non Proprietary Name: | valacyclovir hydrochloride |
| Active Ingredient(s): | 500 mg/1 & nbsp; valacyclovir hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Valacyclovir Hydrochloride
| Product NDC: | 51079-093 |
| Labeler Name: | Mylan Institutional Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078518 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120925 |
Package Information of Valacyclovir Hydrochloride
| Package NDC: | 51079-093-03 |
| Package Description: | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-093-03) > 1 TABLET, FILM COATED in 1 BLISTER PACK (51079-093-01) |
NDC Information of Valacyclovir Hydrochloride
| NDC Code | 51079-093-03 |
| Proprietary Name | Valacyclovir Hydrochloride |
| Package Description | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-093-03) > 1 TABLET, FILM COATED in 1 BLISTER PACK (51079-093-01) |
| Product NDC | 51079-093 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | valacyclovir hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120925 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Institutional Inc. |
| Substance Name | VALACYCLOVIR HYDROCHLORIDE |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |
